I watched it with great interest: it is truly inspirational. To summarise, I wrote a post on the #opensource transition in #pharma, #publichealth, and the need for more #RSE and statistical capacity building in academia. #rstats@rOpenSci@posit_pbc@Roche https://t.co/vAN2fF5gjq
In 2023, @Roche & @genentech are shifting to #opensource as default for #clinicalworkflows & trials!!
Join live pres on Jan 11th, 23 @ 12pm ET:
On YouTube Live so no need to register
https://t.co/A4QGGYCWhc
Reminder for calendar: https://t.co/MDlYvFjUvy
See you there!
#rstats
Quarto for Academics.
@minebocek with a video and blog post highlighting some of Quarto’s features that are especially useful for academics, as educators & as researchers.
Blog: https://t.co/PNzjxYVVjN
Video: https://t.co/aaBYWVB94y
Repo: https://t.co/CJYlkWZvrS
#pydata#rstats
Next Thursday - May 4 - Shirley Wang from @harvardmed will present the #RCTDUPLICATE project at our @UZH_ch#ReproT 🍵. Find the latest results of the project in her recently published @JAMANetwork paper (doi: 10.1001/jama.2023.4221).
For zoom link visit: https://t.co/mkS8KdqraO
Lectures to med students focused on pandemic response this week- here's a short analysis published in @Nature on five key steps. https://t.co/gS4xDdPKYL
@turingway Looks interesting! (this might be a Twitter API thing, but I can't open the links from Twitter even though the links are perfectly fine ... could you post the details at fosstodon as well? Thank you @MalvikaSharan 🥰
It's been a little while, but here are 7 new books added to @BigBookofR . Thanks to @Niels_Bremen for his help in reviewing submissions. #RStats https://t.co/eIq0Uj0pzV
I have completed the course by @Roche@genentech on DS and clinical reporting, recommended! @rinpharma#rstats#pharmaverse
I've written a short review with links to my notes for each module, in case useful in the future: https://t.co/GmKh4s5jBI
Exciting NEW @coursera course "Making Data Science Work for Clinical Reporting" by @Roche & @genentech is out!
https://t.co/LuKLu6QDsK
@Kjmartinstats#rinpharma 2022 talk covers the course vision of using open-source tools for clinical trials!
https://t.co/dZPrtfMH7K
#rstats
Very excited to share our #ReproducibiliTea schedule for the spring semester. The first two contributions will be on-site, while all remaining ones will be on Zoom. Save the dates, spread the word and brew some tea 🍵.
The zoom links will be posted here: https://t.co/CmAzsL6EEA
What does the end of the public health emergency mean for vaccines, treatments, disease surveillance, and more? @dr_kkjetelina and I have a roundup of what to expect in May. https://t.co/vKT7QygKEp
📣 Resources from {targets} in Action Community Call posted!
https://t.co/FWZUrYAy2G
☑️ video+captions
☑️ speakers' slides & example code
☑️ collaborative notes w/ transcript and Q&A
☑️ {targets} books
Speakers: @wmlandau@joel_nitta@LeafyEricScott#RStats
Exploratory data analysis is a challenge for beginners.
So I made a short tutorial the uncovers my 3-Step #EDA Process. ❤️
Article: https://t.co/wbbZZ7stNY
#rstats#datascience
Data science leaders across Roche, GSK, AstraZeneca, Eli Lilly, and Pfizer have joined us to share their perspectives on open source in pharma.
We’ve compiled highlights from each event into the piece, ‘Open source in pharma from five perspectives'.
🔗https://t.co/OWHKtd6XJZ
We launched 🇳🇴 Norway’s Reproducibility Network exactly a year ago! 🎈Happy birthday #NORRN!
Sign up for our newsletter to get new exciting updates on our #Education and #Research activities within #OpenScience and #Reproducibility and get in touch if you want to get involved!
Resume screening is pretty much a black box for most candidates. Few hiring managers have publicly discussed this.
Whether you're interested in our startup, I hope my perspective can shed some light on what is happening on the other side of the table.
https://t.co/wsoJV1fI9z